Advertisement
Document › Details
Fluidigm Corporation. (8/28/17). "Press Release: Fluidigm to Participate in Two Upcoming Health Care Conferences in September". South San Francisco, CA.
Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in two upcoming health care conferences in New York, NY.
Morgan Stanley 15th Annual Global Health Care Conference
Linthwaite will participate in a fireside chat presentation on Monday, September 11, at 4:50 pm ET at the Grand Hyatt New York.
Cantor Fitzgerald Healthcare Conference
Linthwaite will also present on Tuesday, September 26, at 4:00 pm ET at the InterContinental New York Barclay Hotel.
Live webcasts of the company's presentations and subsequent replays may be accessed at http://investors.fluidigm.com/events.cfm. The webcasts will be archived for 90 days following the live presentations.
About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.
Contact:
Fluidigm Corporation
Ana Petrovic
Director, Corporate Development and Investor Relations
650.243.6628 (Office)
ana.petrovic@fluidigm.com
Record changed: 2023-06-05 |
Advertisement
More documents for Fluidigm (Group)
- [1] Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA....
- [2] Fluidigm Corporation. (3/28/22). "Press Release: Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution". South San Francisco, CA....
- [3] Fluidigm Corporation. (1/24/22). "Press Release: Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.". South San Francisco, CA....
- [4] Fluidigm Corporation. (9/2/21). "Press Release: Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference". South San Francisco, CA....
- [5] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Announces First Quarter 2020 Financial Results". South San Francisco, CA....
- [6] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA....
- [7] Fluidigm Corporation. (3/16/20). "Press Release: Consortium of Medical Schools Led by Mount Sinai Fast-Tracking COVID-19 Detection Test Utilizing Fluidigm Microfluidics Technology". South San Francisco, CA....
- [8] Fluidigm Corporation. (3/10/20). "Press Release: Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research". South San Francisco, CA....
- [9] Fluidigm Corporation. (3/3/20). "Press Release: Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing". South San Francisco, CA & Hinxton....
- [10] Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top